HK1211863A1 - Substituted isoxazole amine compounds as inhibitors of scd1 scd1 - Google Patents

Substituted isoxazole amine compounds as inhibitors of scd1 scd1

Info

Publication number
HK1211863A1
HK1211863A1 HK15112883.8A HK15112883A HK1211863A1 HK 1211863 A1 HK1211863 A1 HK 1211863A1 HK 15112883 A HK15112883 A HK 15112883A HK 1211863 A1 HK1211863 A1 HK 1211863A1
Authority
HK
Hong Kong
Prior art keywords
scd1
inhibitors
amine compounds
substituted isoxazole
isoxazole amine
Prior art date
Application number
HK15112883.8A
Other languages
English (en)
Chinese (zh)
Inventor
Johnmark Derryberry
Shawn David Erickson
Paul Gillespie
Eric Mertz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1211863A1 publication Critical patent/HK1211863A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
HK15112883.8A 2012-12-03 2015-12-31 Substituted isoxazole amine compounds as inhibitors of scd1 scd1 HK1211863A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261732463P 2012-12-03 2012-12-03
PCT/EP2013/075035 WO2014086667A1 (en) 2012-12-03 2013-11-29 Substituted isoxazole amine compounds as inhibitors of scd1

Publications (1)

Publication Number Publication Date
HK1211863A1 true HK1211863A1 (en) 2016-06-03

Family

ID=49709654

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112883.8A HK1211863A1 (en) 2012-12-03 2015-12-31 Substituted isoxazole amine compounds as inhibitors of scd1 scd1

Country Status (11)

Country Link
US (1) US9290465B2 (pt)
EP (1) EP2925408A1 (pt)
JP (1) JP2016501210A (pt)
KR (1) KR20150091071A (pt)
CN (1) CN104822420A (pt)
BR (1) BR112015012877A2 (pt)
CA (1) CA2890300A1 (pt)
HK (1) HK1211863A1 (pt)
MX (1) MX2015006930A (pt)
RU (1) RU2015123276A (pt)
WO (1) WO2014086667A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA46589A (fr) 2016-10-24 2019-08-28 Yumanity Therapeutics Inc Composés et utilisations de ces derniers
CN110392833A (zh) 2017-01-06 2019-10-29 优曼尼蒂治疗公司 治疗神经病症的方法
US11873298B2 (en) 2017-10-24 2024-01-16 Janssen Pharmaceutica Nv Compounds and uses thereof
EP3914593A4 (en) 2019-01-24 2022-11-02 Yumanity Therapeutics, Inc. COMPOUNDS AND THEIR USES
CN112724157B (zh) * 2021-01-23 2022-04-19 中国科学院新疆理化技术研究所 二氢噁唑并[5,4-d]吡咯并[1,2-a]嘧啶-9(5H)-酮类衍生物及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515483A (pt) * 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
AU2008241313A1 (en) * 2007-04-20 2008-10-30 Merck Frosst Canada Ltd. Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
US20100249192A1 (en) * 2007-12-11 2010-09-30 Merck Frosst Canada Ltd. Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase

Also Published As

Publication number Publication date
US9290465B2 (en) 2016-03-22
CN104822420A (zh) 2015-08-05
WO2014086667A1 (en) 2014-06-12
MX2015006930A (es) 2015-09-08
RU2015123276A (ru) 2017-01-13
CA2890300A1 (en) 2014-06-12
BR112015012877A2 (pt) 2018-04-24
JP2016501210A (ja) 2016-01-18
KR20150091071A (ko) 2015-08-07
EP2925408A1 (en) 2015-10-07
US20150315160A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
IL245309B (en) Heterocyclic tricyclic compounds as jak inhibitors
HK1212693A1 (zh) 作為溴結構域抑制劑的新的雜環化合物
ZA201309561B (en) Novel inhibitor compounds of phosphodiestarase type 10a
HK1201519A1 (en) Inhibitors of phosphodiesterase type 10a 10a
IL234845A0 (en) Isocazole as a beta-lactamase inhibitor
HK1209126A1 (en) Ring constrained analogs as arginase inhibitors
CO6960542A2 (es) Polimorfos de inhibidores de cinasas
AP4029A (en) Inhibitors of beta-secretase
EP2903613A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
EP2903617A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
SMT201600328B (it) Nuovi composti come inibitori di diacilglicerolo aciltransferasi
HK1211024A1 (en) Inhibitors of syk syk
IL236963A0 (en) beta-secretase inhibitors
HK1211863A1 (en) Substituted isoxazole amine compounds as inhibitors of scd1 scd1
EP2758387A4 (en) Pyridine compounds as kinase inhibitors
HK1206728A1 (en) Novel inhibitor compounds of phosphodiesterase type 10a 10a
HK1201523A1 (en) Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a 10a
PL2888228T3 (pl) Inhibitory oddziaływania CD40-TRAF6
HK1209123A1 (en) Substituted isoxazole amide compounds as inhibitors of stearoyl-coa desaturase 1 (scd1) a 1(scd1)
CR20130603A (es) Compuestos novedosos como inhibidores de diacilglicerol
EP2680843A4 (en) DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS
HK1211581A1 (en) Novel inhibitor compounds of phosphodiesterase type 10a 10a
HK1211284A1 (en) Inhibitor compounds of phosphodiesterase type 10a 10a
EP2847163A4 (en) IRON-CHELATORS AS HIV-1 INHIBITORS